Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Adlai Nortye Ltd.

Adlai Nortye Reports Unaudited First Half 2024 Financial Results and Highlights Recent Operational Progress
From Adlai Nortye Ltd.
Via GlobeNewswire
Tickers ANL
Adlai Nortye Appoints Roger Sawhney, M.D. to Its Board of Directors
From Adlai Nortye Ltd.
Via GlobeNewswire
Tickers ANL
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024
From Adlai Nortye Ltd.
Via GlobeNewswire
Tickers ANL
Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy
From Adlai Nortye Ltd.
Via GlobeNewswire
Tickers ANL
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development
From Adlai Nortye Ltd.
Via GlobeNewswire
Tickers ANL
Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC
From Adlai Nortye Ltd.
Via GlobeNewswire
Tickers ANL
Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award
From Adlai Nortye Ltd.
Via GlobeNewswire
Tickers ANL
Adlai Nortye Ltd. Announces Closing of Initial Public Offering
From Adlai Nortye Ltd.
Via GlobeNewswire
Tickers ANL
Adlai Nortye Ltd. Announces Pricing of Initial Public Offering
From Adlai Nortye Ltd.
Via GlobeNewswire
Tickers ANL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
Privacy Policy  |  Terms of Use  |  MNG Corporate Site Map  |  Copyright